Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for upper gastrointestinal bleeding
IRCT20130812014333N92Phase 2Not yet recruiting
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2638
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of tranexamic acid in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Amount of upper gastrointestinal bleeding. Planned start May 2638; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on IRCT20130812014333N92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N92.